Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
The Alternative Lengthening of Telomeres (ALT) pathway is a telomerase-independent pathway for telomere maintenance that is active in a significant subset of human cancers and in vitro immortalized cell lines. ALT is thought to involve templated extension of telomeres through homologous recombination, but the genetic or epigenetic changes that unleash ALT are not known. Recently, mutations in the ATRX/DAXX chromatin remodeling complex and histone H3.3 were found to correlate with features of ALT in pancreatic neuroendocrine cancers, pediatric glioblastomas, and other tumors of the central nervous system, suggesting that these mutations might contribute to the activation of the ALT pathway in these cancers. We have taken a comprehensive approach to deciphering ALT by applying genomic, molecular biological, and cell biological approaches to a panel of 22 ALT cell lines, including cell lines derived in vitro. Here we show that loss of ATRX protein and mutations in the ATRX gene are hallmarks of ALT–immortalized cell lines. In addition, ALT is associated with extensive genome rearrangements, marked micronucleation, defects in the G2/M checkpoint, and altered double-strand break (DSB) repair. These attributes will facilitate the diagnosis and treatment of ALT positive human cancers.
Vyšlo v časopise:
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway. PLoS Genet 8(7): e32767. doi:10.1371/journal.pgen.1002772
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002772
Souhrn
The Alternative Lengthening of Telomeres (ALT) pathway is a telomerase-independent pathway for telomere maintenance that is active in a significant subset of human cancers and in vitro immortalized cell lines. ALT is thought to involve templated extension of telomeres through homologous recombination, but the genetic or epigenetic changes that unleash ALT are not known. Recently, mutations in the ATRX/DAXX chromatin remodeling complex and histone H3.3 were found to correlate with features of ALT in pancreatic neuroendocrine cancers, pediatric glioblastomas, and other tumors of the central nervous system, suggesting that these mutations might contribute to the activation of the ALT pathway in these cancers. We have taken a comprehensive approach to deciphering ALT by applying genomic, molecular biological, and cell biological approaches to a panel of 22 ALT cell lines, including cell lines derived in vitro. Here we show that loss of ATRX protein and mutations in the ATRX gene are hallmarks of ALT–immortalized cell lines. In addition, ALT is associated with extensive genome rearrangements, marked micronucleation, defects in the G2/M checkpoint, and altered double-strand break (DSB) repair. These attributes will facilitate the diagnosis and treatment of ALT positive human cancers.
Zdroje
1. BryanTMEnglezouADalla-PozzaLDunhamMAReddelRR 1997 Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3 1271 1274
2. DunhamMANeumannAAFaschingCLReddelRR 2000 Telomere maintenance by recombination in human cells. Nat Genet 26 447 450
3. BechterOEShayJWWrightWE 2004 The Frequency of Homologous Recombination in Human ALT Cells. Cell Cycle 3 457 549
4. Londono-VallejoJADer-SarkissianHCazesLBacchettiSReddelRR 2004 Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res 64 2324 2327
5. CesareAJGriffithJD 2004 Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 24 9948 9957
6. WangRCSmogorzewskaAde LangeT 2004 Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119 355 368
7. TokutakeYMatsumotoTWatanabeTMaedaSTaharaH 1998 Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem Biophys Res Commun 247 765 772
8. HensonJDCaoYHuschtschaLIChangACAuAY 2009 DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Biotechnol 27 1181 1185
9. McEachernMJHaberJE 2005 Telomerase-independent telomere maintenance in yeast. de LangeTLundbladVBlackburnE Telomeres Cold Spring Harbor, New York Cold Spring Harbor Laboratory Press 199 224
10. HensonJDNeumannAAYeagerTRReddelRR 2002 Alternative lengthening of telomeres in mammalian cells. Oncogene 21 598 610
11. YeagerTRNeumannAAEnglezouAHuschtschaLINobleJR 1999 Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59 4175 4179
12. JiangWQZhongZHHensonJDNeumannAAChangAC 2005 Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol Cell Biol 25 2708 2721
13. ComptonSAChoiJHCesareAJOzgurSGriffithJD 2007 Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res 67 1513 1519
14. PottsPRYuH 2007 The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol 14 581 590
15. ZengSXiangTPanditaTKGonzalez-SuarezIGonzaloS 2009 Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol 11 616 623
16. HeaphyCMSubhawongAPHongSMGogginsMGMontgomeryEA 2011 Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179 1608 1615
17. HensonJDReddelRR 2010 Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Lett 584 3800 3811
18. HensonJDHannayJAMcCarthySWRoydsJAYeagerTR 2005 A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11 217 225
19. SfeirAKabirSvan OverbeekMCelliGBde LangeT 2010 Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 327 1657 1661
20. KibeTOsawaGAKeeganCEde LangeT 2010 Telomere protection by TPP1 Is mediated by POT1a and POT1b. Mol Cell Biol 30 1059 1066
21. RaiRZhengHHeHLuoYMultaniA 2010 The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J 29 2598 2610
22. WangYGhoshGHendricksonEA 2009 Ku86 represses lethal telomere deletion events in human somatic cells. Proc Natl Acad Sci U S A 106 12430 12435
23. CelliGBLazzerini DenchiEde LangeT 2006 Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol 8 885 890
24. HeaphyCMde WildeRFJiaoYKleinAPEdilBH 2011 Altered telomeres in tumors with ATRX and DAXX mutations. Science 333 425
25. JiaoYShiCEdilBHde WildeRFKlimstraDS 2011 DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331 1199 1203
26. SchwartzentruberJKorshunovALiuXYJonesDTPfaffE 2012 Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482 226 231
27. DranePOuararhniKDepauxAShuaibMHamicheA 2010 The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 24 1253 1265
28. LawMJLowerKMVoonHPHughesJRGarrickD 2010 ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell 143 367 378
29. WongLHMcGhieJDSimMAndersonMAAhnS 2010 ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res 20 351 360
30. LewisPWElsaesserSJNohKMStadlerSCAllisCD 2010 Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A 107 14075 14080
31. GoldbergADBanaszynskiLANohKMLewisPWElsaesserSJ 2010 Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140 678 691
32. AzzalinCMReichenbachPKhoriauliLGiulottoELingnerJ 2007 Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318 798 801
33. BaumannCViveirosMMDe La FuenteR 2010 Loss of maternal ATRX results in centromere instability and aneuploidy in the mammalian oocyte and pre-implantation embryo. PLoS Genet 6 e1001137 doi:10.1371/journal.pgen.1001137
34. De La FuenteRViveirosMMWigglesworthKEppigJJ 2004 ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. Dev Biol 272 1 14
35. RitchieKSeahCMoulinJIsaacCDickF 2008 Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol 180 315 324
36. IshovAMVladimirovaOVMaulGG 2004 Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J Cell Sci 117 3807 3820
37. XueYGibbonsRYanZYangDMcDowellTL 2003 The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A 100 10635 10640
38. NgLJCropleyJEPickettHAReddelRRSuterCM 2009 Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res 37 1152 1159
39. BeroukhimRMermelCHPorterDWeiGRaychaudhuriS 2010 The landscape of somatic copy-number alteration across human cancers. Nature 463 899 905
40. DavoliTDenchiELde LangeT 2010 Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141 81 93
41. ArtandiSEChangSLeeSLAlsonSGottliebGJ 2000 Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406 641 645
42. ScheelCSchaeferKLJauchAKellerMWaiD 2001 Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20 3835 3844
43. CounterCMAvilionAALeFeuvreCEStewartNGGreiderCW 1992 Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. Embo J 11 1921 1929
44. ChinKDe SolorzanoCOKnowlesDJonesAChouW 2004 In situ analyses of genome instability in breast cancer. Nat Genet 36 984 988
45. CrastaKGanemNJDagherRLantermannABIvanovaEV 2012 DNA breaks and chromosome pulverization from errors in mitosis. Nature 482 53 58
46. BakouKStephanouGAndrianopoulosCDemopoulosNA 2002 Spontaneous and spindle poison-induced micronuclei and chromosome non-disjunction in cytokinesis-blocked lymphocytes from two age groups of women. Mutagenesis 17 233 239
47. StrackerTHWilliamsBRDerianoLTheunissenJWAdelmanCA 2009 Artemis and nonhomologous end joining-independent influence of DNA-dependent protein kinase catalytic subunit on chromosome stability. Mol Cell Biol 29 503 514
48. Lu-HesselmannJAbendMvan BeuningenD 2004 Comparison of endogenous TP53 genomic status with clonogenicity and different modes of cell death after X irradiation. Radiat Res 161 39 47
49. BrownEJBaltimoreD 2003 Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev 17 615 628
50. KimSTXuBKastanMB 2002 Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev 16 560 570
51. AbreuEAritonovskaEReichenbachPCristofariGCulpB 2010 TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol Cell Biol 30 2971 2982
52. CesareAJKaulZCohenSBNapierCEPickettHA 2009 Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nat Struct Mol Biol 16 1244 1251
53. TurnerNTuttAAshworthA 2005 Targeting the DNA repair defect of BRCA tumours. Curr Opin Pharmacol 5 388 393
54. BucherNBrittenCD 2008 G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer 98 523 528
55. JacksonSPBartekJ 2009 The DNA-damage response in human biology and disease. Nature 461 1071 1078
56. TakaiKKHooperSBlackwoodSGandhiRde LangeT 2010 In vivo stoichiometry of shelterin components. J Biol Chem 285 1457 1467
57. SjoblomTJonesSWoodLDParsonsDWLinJ 2006 The consensus coding sequences of human breast and colorectal cancers. Science 314 268 274
58. Cancer Genome Atlas Research Network 2008 Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 1061 1068
59. MermelCHSchumacherSEHillBMeyersonMLBeroukhimR 2011 GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12 R41
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 7
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Guidelines for Genome-Wide Association Studies
- The Role of Rice HEI10 in the Formation of Meiotic Crossovers
- Identification of Chromatin-Associated Regulators of MSL Complex Targeting in Dosage Compensation
- GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers